📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort. (2022)

First Author: Handy A

Attributed to: Characterisation, determinants, mechanisms and consequences of the long-term effects of COVID-19: providing the evidence base for health care funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/heartjnl-2021-320325

PubMed Identifier: 35273122

Publication URI: http://europepmc.org/abstract/MED/35273122

Type: Journal Article/Review

Volume: 108

Parent Publication: Heart (British Cardiac Society)

Issue: 12

ISSN: 1355-6037